Next Quarterly Earnings
Wednesday, November 11, 2026
CW 46
Pre-Market
In 76 days
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Teva Pharmaceutical Industries ADR
Teva Pharmaceutical Industries ADR is a global leader in the pharmaceutical sector, headquartered in Israel. The company focuses on the development and production of high-quality generic medicines and specialty pharmaceuticals to make global healthcare more efficient, accessible, and affordable for all.
Frequently asked questions
When will Teva Pharmaceutical Industries ADR report its next quarterly earnings?
Teva Pharmaceutical Industries ADR is scheduled to report its next quarterly earnings on 11/11/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
When did Teva Pharmaceutical Industries ADR last report quarterly earnings?
Teva Pharmaceutical Industries ADR last reported quarterly earnings on 7/29/2026 (Q2 2026). Earnings per share (EPS) came in at 0.02 USD.
How does Teva Pharmaceutical Industries ADR stock react to earnings?
Across its last 5 earnings reports, Teva Pharmaceutical Industries ADR stock moved by ±11.5% on average the following day. The largest reaction was +20.2% on 11/05/2025; 4 of 5 reactions were positive.
How often has Teva Pharmaceutical Industries ADR beaten expectations?
Teva Pharmaceutical Industries ADR has beaten analyst EPS estimates in 4 of its last 5 evaluated quarters (beat rate: 80%).
How do I add the Teva Pharmaceutical Industries ADR earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
All Dates
Earnings statistics
Stock reaction to earnings
±11.5%
Avg. next-day move
+20.2%
Largest move (11/05/2025)
80%
Share of positive reactions
±15.7%
Avg. move after 7 days
Basis: price reactions to the last 5 report dates (close to close).
Estimates vs. results
4/5
Quarters above estimates
80%
Beat rate
+0.2%
Avg. EPS surprise
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.